Inventor
MERRIL CARL R
US27 patents
⚠️ This page may combine multiple inventors who share the name “MERRIL CARL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
13 patentsUS5468610ANov 21, 1995
Three highly informative microsatellite repeat polymorphic DNA markers
US HEALTH73 citations96
US5369004ANov 29, 1994
Five highly informative microsatellite repeat polymorphic DNA markers
US HEALTH59 citations96
US4555490ANov 26, 1985
Rapid visualization system for gel electrophoresis
US HEALTH57 citations96
US5817797AOct 6, 1998
Sequencing DNA; a modification of the polymerase chain reaction
US HEALTH27 citations92
US4405720ASep 20, 1983
Silver stains for protein in gels
US HEALTH48 citations92
US5378602AJan 3, 1995
Highly informative microsatellite repeat polymorphic DNA markers twenty-[seven]six
US HEALTH76 citations91
US4892814AJan 9, 1990
Method for distinguishing Creutzfeldt-Jakob disease from other dementias
US HEALTH28 citations89
US7332307B2Feb 19, 2008
Antibacterial therapy with bacteriophage physico-chemically altered by pegylation to delay inactivation by the host defense system
US HEALTH12 citations83
US4703016AOct 27, 1987
Silver stain for rapid, quantitative detection of polypeptides and nucleic acids
US HEALTH23 citations82
US5721100AFeb 24, 1998
Three highly informative microsatellite repeat polymorphic DNA markers
US HEALTH6 citations74
US4508820AApr 2, 1985
Method for simultaneously monitoring turnover rate in multiple proteins
US HEALTH14 citations74
US7163818B2Jan 16, 2007
Bacteriophage having multiple host range
US HEALTH7 citations70
US5861504AJan 19, 1999
Eleven highly informative microsatelite repeat polymorphic DNA markers
US HEALTH3 citations63
EXPONENTIAL BIOTHERAPIES INC
4 patentsUS5688501ANov 18, 1997
Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system
EXPONENTIAL BIOTHERAPIES INC112 citations97
US5811093ASep 22, 1998
Bacteriophage genotypically modified to delay inactivations by the host defense system
EXPONENTIAL BIOTHERAPIES INC72 citations94
US5766892AJun 16, 1998
Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system together with an antibiotic
EXPONENTIAL BIOTHERAPIES INC41 citations94
US5660812AAug 26, 1997
Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system
EXPONENTIAL BIOTHERAPIES INC32 citations91
MONOCLONETICS INT
4 patentsUS5844097ADec 1, 1998
Methods for the diagnosis of peripheral nerve damage
MONOCLONETICS INT37 citations87
US4940659AJul 10, 1990
Screening extra-cellular body fluids for superoxide dismutase (SOD-1) for determining fetal trisomy 21 down syndrome
MONOCLONETICS INT23 citations86
US5583201ADec 10, 1996
Methods for diagnosis of peripheral nerve damage
MONOCLONETICS INT18 citations77
US5364793ANov 15, 1994
Methods for the diagnosis of peripheral nerve damage
MONOCLONETICS INT15 citations77
PANACEA PHARMACEUTICALS INC
3 patentsUS9744223B2Aug 29, 2017
Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)
PANACEA PHARMACEUTICALS INC4 citations71
US7521479B2Apr 21, 2009
Methods of treating prion disease in mammals
PANACEA PHARMACEUTICALS INC3 citations62
US10702591B2Jul 7, 2020
Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylase
PANACEA PHARMACEUTICALS INC0 citations48